Table 5.
Acute predisposing agent | Total cases predisposed, N (%) | Followed up cases, N (%) | Cases died, N (%) |
---|---|---|---|
Single insult | 88 (71.54) | 62 (70.45) | 40 (66.12) |
Alcohol intake | 30 (34.09) | 22 (73.33) | 21 (95.45) |
HAV infection | 6 (6.81) | 6 (4.87) | 3 (50) |
HBV flare | 7 (7.95) | 5 (71.42) | 3 (60) |
Infection | 22 (25) | 16 (69.56) | 6 (37.5) |
Hepatotoxic medication | 6 (6.81) | 3 (50) | 1 (33.33) |
Variceal bleed | 2 (2.27) | 1 (50) | 0 (0) |
Unknown predisposition | 15 (17.04) | 9 (60) | 7 (77.77) |
Multiple insults (Probable sequential order of individual acute insults) | 35 (28.45) | 27 (77.14) | 22 (81.48) |
Alcohol intake → Infection | 12 (34.28) | 10 (37.03) | 9 (90) |
Alcohol intake → Indigenous drugs | 6 (17.14) | 4 (14.81) | 2 (50) |
Infections → Indigenous drugs | 4 (11.42) | 2 (7.4) | 2 (100) |
Infections → Variceal bleed | 3 (8.57) | 2 (7.4) | 1 (50) |
Infection → Falciparum malaria | 3 (8.57) | 2 (7.4) | 1 (50) |
Alcohol intake → Acute HAV infection | 2 (5.71) | 2 (7.4) | 2 (100) |
Alcohol intake → Variceal bleed | 1 (2.85) | 1 (3.7) | 1 (100) |
Alcohol intake → HBV Flare → Antitubercular drugs | 2 (5.71) | 2 (7.4) | 2 (100) |
Acute HEV Infection → Indigenous drugs → Infection | 1 (2.85) | 1 (3.7) | 1 (100) |
Acute HAV infection → Indigenous drugs → Infection | 1 (2.85) | 1 (3.7) | 1 (100) |
N: number; →: followed by; HAV: hepatitis A virus; HBV: hepatitis B virus; HEV: hepatitis B virus.